Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02846038 · ClinicalTrials.gov registry record

Understanding Communication in Healthcare to Achieve Trust (U-CHAT)

A clinical trial, sponsored by St. Jude Children's Research Hospital.

Completed
Registry status
138
Enrollment target

NCT02846038: Completed study, sponsored by St. Jude Children's Research Hospital.

NCT02846038 is a clinical trial that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 138 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02846038 has completed, sponsored by St. Jude Children's Research Hospital.

COMPLETED
Registry status
138 participants
Enrollment target

Study Summary

Honest, clear, and empathetic communication between pediatric oncologists (POs) and parents of children with cancer (POCCs) is imperative to facilitating therapeutic alliance and ensuring that medical management aligns with the families' goals of care. Communication is particularly important during conversations about disease reevaluation, which often necessitate parental decision-making in the context of emotional distress. POs employ a spectrum of communication styles and strategies during challenging conversations, and there is no consensus regarding linguistic or thematic metrics for high quality communication of upsetting information. In order to better understand how POs communicate difficult information to POCCs, the investigators propose a pilot study designed to accomplish the following primary aim: Primary Objective: * To identify recurrent verbal and nonverbal (e.g. the use of pauses/silence) communication techniques employed by POs in the delivery of difficult prognostic information to POCCs through content analysis of audio-recorded conversations between POs and parents of children with high risk cancer at the time of disease reevaluation. The study expects to enroll up to: 80 patient participants, 80 parents, and 15 primary pediatric oncologists (total = 175). Non-primary oncologist members of the clinical care team, extended family members, or friends of the family may also participate, if they choose to do so.

Trial Details

FieldValue
Enrollment Target 138 participants
Start Date 2016-09-09
Est. Completion 2024-04-10

What the finished NCT02846038 record still lists

NCT02846038 is an observational study that tracks outcomes without assigning an intervention. The registered 138 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT02846038 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02846038 about?

NCT02846038 is a clinical study titled "Understanding Communication in Healthcare to Achieve Trust (U-CHAT)". Honest, clear, and empathetic communication between pediatric oncologists (POs) and parents of children with cancer (POCCs) is imperative to facilitating therapeutic alliance and ensuring that medical management aligns with the families' goals of care. Communication is particularly important during ...

What is the current status of trial NCT02846038?

This trial is currently completed. The enrollment target is 138 participants. The study started on 2016-09-09. Estimated completion is 2024-04-10.

Who is sponsoring clinical trial NCT02846038?

This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04402788 · 138 participants · Phase 2

    Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial

  • NCT04883255 · 138 participants · Early Phase 1

    Cannabis Use, Cognition, and the Endocannabinoid System in HIV

  • NCT05620784 · 138 participants · Phase 3

    Intra-operative Loop Diuretics to Improve Same-day Discharge Rates After HoLEP

  • NCT05832086 · 138 participants · Phase 2

    Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02846038, the US trial registry maintained by the National Library of Medicine. NCT02846038 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.